Search Results for:

Corona Vaccine In Childrens

April 24, 2024

Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization in Children and Adolescents — United States, 2021–2023 | Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen |
The Persistence of SARS-CoV-2 in Tissues and its Association with Long COVID Symptoms: A Cross-sectional Cohort Study in China

Impact of SARS-CoV-2

April 17, 2024

Systematic Analyses of the Factors Influencing Sperm Quality in Patients with SARS-CoV-2 Infection |
Nirmatrelvir/ritonavir and Remdesivir against Symptomatic Treatment in High-risk COVID-19 Outpatients to Prevent Hospitalization or Death During the Omicron Era: A Propensity Score-matched Study |
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19

Corona Vaccine in Rural Area

April 11, 2024

Rural-urban Differences in Long-term Mortality and Readmission Following COVID-19 Hospitalization | Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with COVID-19 |
Brain and Cognitive Changes in Patients with Long COVID Compared with Infection-recovered Control Subjects | Incident Allergic Diseases in Post-COVID-19 Condition: Multinational Cohort Studies from South Korea, Japan and the UK |
Functional Limitations and Exercise Intolerance in Patients with Post-COVID Condition

Covid Phase

April 3, 2024

Interplay of Inflammatory Markers and Anti-SARS-CoV-2 Antibodies in COVID-19 | Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity | Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease |
Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs |
Paxlovid Use is Associated with Lower Risk of Cardiovascular Diseases in COVID-19 Patients with Autoimmune Rheumatic Diseases

Covid Treatment

March 28, 2024

COVID-19 Rebound After VV116 vs Nirmatrelvir-Ritonavir Treatment – A Randomized Clinical Trial | Joint Analysis of Vaccination Effectiveness and Antiviral Drug Effectiveness for COVID-19: A Causal Inference Approach | Timing and Predictors of Loss of Infectivity Among Healthcare Workers with Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study |
Household Transmission Dynamics of Asymptomatic SARS-CoV-2–Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study

Covid Oximeter

March 21, 2024

Lower vs Higher Oxygenation Target and Days Alive Without Life Support in COVID-19: The HOT-COVID Randomized Clinical Trial |
Prevalence of Orthostatic Intolerance in Long COVID Clinic Patients and Healthy Volunteers: A Multicenter Study | Autonomic Cardiac Function in Children and Adolescents with Long COVID: A Case-controlled Study | Iron Dysregulation and Inflammatory Stress Erythropoiesis Associates with Long-term Outcome of COVID-19

Comparative study findings

March 14, 2024

Vaccine Effectiveness Against Long COVID in Children | Impact of Vaccination on the Association of COVID-19 with Cardiovascular Diseases: An OpenSAFELY Cohort Study | The Impacts of Nirmatrelvir–Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave of the Pandemic

COVID: Active Vaccination/Immunity

March 7, 2024

Interim Effectiveness of Updated 2023–2024 COVID-19 Vaccines Against COVID-19 | Combined Protection of Vaccination and Nirmatrelvir-ritonavir in Adults |
Ivermectin for COVID-19 in Adults in the Community (PRINCIPLE): An Open, Randomised, Controlled, Adaptive Platform |
Cognition and Memory after COVID-19 in a Large Community Sample |
Prospective Memory Assessment Before and After Covid-19 |
What is the Impact of Long-term COVID-19 on Workers

Compilation of studies

February 29, 2024

Effectiveness of Nirmatrelvir-ritonavir on Severe Outcomes of COVID-19 in the Era of Vaccination | Randomized Controlled Trial of Molnupiravir SARS-CoV-2 Viral and Antibody Response | Spontaneous, Persistent, T cell–dependent IFN-γ Release in Patients | Blood–brain Barrier Disruption and Sustained Systemic Inflammation in Individuals |
Prevalence of Persistent SARS-CoV-2 in a Large Community Surveillance Study | Long Term Outcomes of Hyperbaric Oxygen Therapy in Post Covid Condition

Receive updates about Parasites without Borders initiatives, developments, and learn more about parasites by subscribing to our periodic newsletter.


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Parasites Without Borders

A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.

Donate to Parasites Without Borders today!

Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.

Scroll to Top